Not provided
Not provided
Not provided
Not provided
Not provided
Sample size calculation would have been overinflated; re-think study design
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This trial hopes to demonstrate the effect of 4 weeks of outpatient exercise rehabilitation on COPD patients. In particular the effect on:
and compare it to the effect of 4 weeks of outpatients rehabilitation with Noninvasive Ventilation as an adjunct therapy.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control Arm | No Intervention | This arm will perform the pulmonary rehabilitation as specified with no respiratory assistance. | |
| Intervention Arm | Active Comparator | This arm will conduct the pulmonary rehabilitation program with BiLevel Noninvasive Ventilation assistance from a ResMed ventilator. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BiLevel Noninvasive Ventilation | Device | Positive pressure applied through an oro-nasal mask. The pressure is altered between inspiration and expiration. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Daily Physical Activity | The primary outcome will be measured by daily activity using accelerometer arm bands. This will be measured at the beginning of the rehabilitation program, at the end and at a 3 month follow up. | 3 Months |
| Exercise Capacity | 6 Minute Walking Distance will be measured every week during the exercise program. | 6 Weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life | Using the St. George Respiratory Questionnaire before and after rehabilitation, quality of life will be measured. | 3 Months |
| Dyspnoea | Change in Dyspnoea after end of exercise will be assessed using the Multidimensional Dyspnoea Profile and the BORG scale. |
| Measure | Description | Time Frame |
|---|---|---|
| Time to pulmonary exacerbation | The average time to exacerbation between groups will be analysed post trial. | 12 Months |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Helmut Teschler, Prof. Dr. med. | Dept. Respiratory & Sleep Medicine - Ruhrlandklinik | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ruhrlandklinik | Tuschen | Hesse | 45239 | Germany |
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 6 Weeks |
| Change in Physiological Parameters | Maximum training intensity, body weight and muscle diameter will be tracked throughout the training program. | 3 Months |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |